Log In Sign up
The largest database of trusted experimental protocols
> Disorders > Sign or Symptom > Vertigo

Vertigo

Vertigo is a sensation of dizziness or spinning, often accompanied by a loss of balance or disorientation.
It can be caused by a variety of underlying conditions, including inner ear disorders, neurological problems, or medication side effects.
Vertigo can significantly impact a person's quality of life, making it difficult to perform everyday tasks.
Proper diagnosis and treatment of the underlying cause are crucial for managing vertigo symptoms and improving patient outcomes.
Researchers studying vertigo may utilize PubCompare.ai to optimize their research, identify the best protocols and products, and enhance reproducibility and accuracy in their vertigo-related studies.

Most cited protocols related to «Vertigo»

1
Standardization of Vestibular Disorder Nomenclature
In 2006, members of the Bárány Society created a working group to standardize nomenclature for vestibular diseases and disorders worldwide. This led to formation of the Committee for Classification Vestibular Disorders of the Bárány Society (CCBS) to oversee development of the first International Classification of Vestibular Disorders (ICVD) [8 (link)]. To date, this process has generated consensus documents defining vestibular symptoms [9 (link)], vestibular migraine [49 (link)], Menière’s disease [51 (link)], BPPV [87 (link)], and vestibular paroxysmia [82 (link)]. Additional definitions are in the offing. In 2010, the CCBS chartered a Behavioral Subcommittee to identify primary and secondary psychiatric disorders that cause or amplify vestibular morbidity and review evidence about the nature of PPV, SMD, VV, and CSD. In keeping with established procedures for the classification process [5 ], the Behavioral Subcommittee included an otologist (A.H.), neurologist (M.S.), and members with special expertise in psychosomatic medicine (J.P.S., A.E.H.) and psychiatry (J.P.S., R.J.). Members hailed from three continents (Asia, Europe, and North America). Two senior neuro-otologists (T.B., A.B.) graciously agreed to advise subcommittee members on their deliberations.
The subcommittee met for the first time in August 2010 during the Bárány Society’s biennial congress in Reykjavík, Iceland. From 2010–2012, the chair (J.P.S.) consulted with subcommittee members individually. These deliberations produced a consensus that PPV, SMD, VV, and CSD included a core set of physical symptoms that represented a distinctly definable vestibular disorder. Subcommittee members prepared a draft definition of this disorder that was updated iteratively after review by the general membership of the Bárány Society in June 2012 in Uppsala, Sweden, the CCBS in November 2013 in Mondorf-les-Bains, Luxembourg, and then again by the general membership in May 2014 in Buenos Aires, Argentina. Additional feedback was solicited from scientific societies dedicated to otorhinolaryngology, neurology, psychiatry, and psychosomatic medicine worldwide and from individual members of the Bárány Society via a posting of the draft definition to the ICVD development webpage of the Journal of Vestibular Research. The subcommittee used this feedback to prepare the final definition, which was approved by the CCBS.
The disorder was named persistent postural-perceptual dizziness to reflect its main diagnostic criteria of persistent non-vertiginous dizziness, unsteadiness, and non-spinning vertigo that are exacerbated by postural challenges and perceptual sensitivity to space-motion stimuli. A separate, 100-word narrative definition was prepared for the World Health Organization as part of the Bárány Society’s recommendations for updates to the vestibular disorders section of the forthcoming 11th edition of the International Classification of Diseases (ICD-11) [97 ].
Staab J.P., Eckhardt-Henn A., Horii A., Jacob R., Strupp M., Brandt T, & Bronstein A. (2017). Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. Journal of Vestibular Research, 27(4), 191-208.
Publication 2017
Benign Paroxysmal Positional Vertigo Diagnosis Hypersensitivity Mental Disorders Migraine Disorders Neurologists Otologists Physical Examination Vertigo Vestibular Diseases Vestibular Labyrinth
2
Metabolic Profiling of Calf Muscle Using 7T MRI
The protocol was approved by the Institutional Review Board. Informed consent was obtained from all participants prior to the study. Twenty healthy adults (twelve females and eight males) age 22–52 years (average 34 years; without diabetes or known vascular disease) were studied supine or prone in a 7T system (Achieva, Philips Medical Systems, Cleveland, OH). Spectra were acquired with a partial-volume quadrature transmit/receive coil customized to fit the shape of a human calf. Axial, coronal, and sagittal T2-weighted turbo spin echo images were initially acquired of the left calf muscle. Typical parameters were: field of view 180 × 180 mm, repetition time (TR) 1,500 ms, echo time (TE) 75 ms, turbo factor 16, and number of acquisitions (NA), 1. Single-voxel stimulated echo acquisition mode (STEAM) (typical parameters: voxel size 5 × 5 × 5 mm3 (∼0.1 ml), TR 2,000 ms, TE 20 ms, spectral BW of 4 kHz, number of points (NP) 4,096 and zero-filled to 8,192 prior to Fourier transform, NA 16, no water suppression) was used to acquire 1H spectra from tibial bone marrow and subcutaneous fat tissue. To correct individual resonances for relaxation effects, T1 and T2 were measured in seven of the subjects. T1 was measured using inversion-recovery, with nine inversion delay times in the range of 5 ms to 3,000 ms, with TR 7 s and TE 40 ms. T2 was measured by using ten TE values from 20 ms to 180 ms, with TR 8 s. Subjects were instructed to move slowly in the scan room. The entire scanning session was 60 min or less and it was well-tolerated by all subjects. All subjects were interviewed after the exam and again at 24 h after the exam. All subjects specifically denied dizziness, nausea, vertigo, headaches, or visual changes.
Ren J., Dimitrov I., Sherry A.D, & Malloy C.R. (2008). Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. Journal of Lipid Research, 49(9), 2055-2062.
Publication 2008
Adult Bone Marrow Diabetes Mellitus ECHO protocol Ethics Committees, Research Females Headache Homo sapiens Inversion, Chromosome Males Muscle Tissue Nausea Subcutaneous Fat Tibia Vascular Diseases Vertigo Vibration
3
Evaluating Menopausal Symptoms in Chinese Women
We conducted a cross-sectional study at the Department of Gynecology, the Sixth Affiliated People’s Hospital of Shanghai Jiao Tong University, Shanghai, People’s Republic of China, between April 2010 and October 2011. We enrolled women newly attending the outpatient clinic who were naïve to treatment with hormone replacement therapy or any traditional Chinese medicine indicated for menopause. Patients with known mental disorders were excluded. The study was approved by the ethics review board of the hospital and each participant provided their written informed consent prior to participation.
During the survey, all participants were required to fill in a demographic form that included information on age, education, income, marital status, occupation, menopausal status, and disease history. Menopausal status was categorized as perimenopause (climacteric transition with irregular menses) and menopause (last menstrual period at least 12 months prior to the survey). Each participant was also required to complete the Chinese version of the MRS (http://www.menopause-rating-scale.info/languages.htm) and the modified KI.1
The order in which each participant completed the MRS and modified KI was entirely at random. Two experienced interviewers (SHF and LCB) provided all the surveys, and answered any questions raised by the participants.
The MRS consists of 11 items categorized into three subscales, ie, sweating/hot flushes, heart discomfort, sleep problems, joint and muscle problems, categorized as somatovegetative symptoms; depressive mood, irritability, anxiety, and physical/mental exhaustion, categorized as psychological symptoms; and sexual problems, bladder problems, and vaginal dryness, categorized as urogenital symptoms. Severity was rated and scored as none (0 points), mild (1 point), moderate (2 points), severe (3 points), and very severe (4 points). The total score possible ranges from 0 to 44. Scores ranging from 0–4, 5–8, 9–15, and 16+ were used to rate the perceived menopausal symptoms as none/minimal, mild, moderate, and severe, respectively.10 (link),16 (link)
The modified KI1 ,17 consists of 13 items (see Appendix A). In addition to the same 11 items included in the original KI,9 (link) the modified version adds urogenital symptoms, including urinary infection and sexual complaints. The original 11 items included sweating/hot flushes, palpitation, vertigo, headache, paresthesia, formication, arthralgia, and myalgia (categorized as somatic symptoms), and fatigue, nervousness, and melancholia categorized as psychological symptoms. A scale ranging from 0 to 3 points is used to describe the severity of the complaints. The weighting factors were the same as those used in the original KI, and provide two points for both urogenital symptoms. The total score ranges from 0 to 63, calculated as the sum of all items by the weighting factor. Scores ranging from 0–6, 7–15, 16–30, and >30 were used to rate the degree of severity as none, mild, moderate, and severe, respectively.1
Tao M., Shao H., Li C, & Teng Y. (2013). Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient preference and adherence, 7, 223-229.
Publication 2013
Anxiety Arthralgia Chinese Climacteric Desiccation Dyssomnias Fatigue Headache Heart Hot Flashes Interviewers Joints Medically Unexplained Symptoms Melancholia Menopause Menstruation Mental Disorders Mentally Ill Persons Mood Muscle Tissue Myalgia Nervousness Paresthesia Patients Perimenopause Respiratory Diaphragm System, Genitourinary Therapy, Hormone Replacement Urinary Bladder Urinary Tract Infection Vagina Vertigo Woman
4
Vestibular Assessment in Balance Impairment
Prior to balance testing, participants complete a questionnaire regarding a history of dizziness and falls in the past 12 months. Balance testing consists of the modified Romberg Test of Standing Balance on Firm and Compliant Support Surfaces. This test examines the participant’s ability to stand unassisted under four test conditions that are designed to specifically test the sensory inputs that contribute to balance— the vestibular system, vision, and proprioception (Table 1; 7 (link)).
Balance testing was scored on a pass/fail basis. Test failure was defined as a subject 1) needing to open their eyes, 2) moving their arms or feet in order to achieve stability, or 3) beginning to fall or requiring operator intervention to maintain balance within a 30 second interval. Each subject who failed a Test Condition was eligible for one more attempt to pass. Because each successive Test Condition was more difficult than the condition preceding it, balance testing was concluded whenever a subject failed to pass a Test Condition (during the initial test or in the re-test). We focused on Test Condition 4 -- standing with eyes closed on a 16”×18”×3” foam pad – in which participants relied primarily on vestibular input. Of 5086 participants, 257 did not pass prior test conditions and did not participate in Test Condition 4. An additional 86 participants had missing data for Test condition 4, for a total of 343 excluded participants (6.7%). The time to failure (measured manually by stopwatch in seconds) was recorded in all subjects who participated in Test Condition 4; for subjects who passed Test Condition 4 the time to failure was set as 30 seconds (the maximum testing time). Further details of balance testing procedures are available (http://www.cdc.gov/nchs/data/nhanes/ba.pdf; 8).
Agrawal Y., Carey J.P., Hoffman H.J., Sklare D.A, & Schubert M.C. (2011). The modified Romberg balance test: normative data in US adults. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 32(8), 1309-1311.
Publication 2011
Arm, Upper Eye Foot Neoplasm Metastasis Proprioception Vestibular Labyrinth Vestibular System Vision
5
International Classification of Vestibular Disorders
The work presented here is part of an ongoing project to develop an International Classification of Vestibular Disorders (ICVD). The ICVD uses a structured process to develop consensus diagnostic criteria for vestibular symptoms and disorders. The process of establishing criteria is overseen by the Classification Committee of the Bárány Society. For each diagnostic category, an international team of content experts from multiple disciplines is established to propose initial criteria based on the best available scientific evidence. For the classification of “Vestibular Migraine of Childhood”, “probable Vestibular Migraine of Childhood” and “Recurrent Vertigo of Childhood”, one member of the Head-ache Classification Committee of the International Headache Society has been delegated to this team in order to add the expertise from the view of headache experts.
The initial criteria were proposed and circulated to the subcommittee members in 2019 and a first draft was presented to the Committee for the Classification of Vestibular Disorders of the Bárány So-ciety. Comments of (sub)committee members were gathered and synthesized. Modified criteria were presented in 2020 to the Committee for the Classification of Vestibular Disorders of the Bárány Society for tentative approval. The definitions presented here are supported by a process of discussion and refinement as established by the classification committee for the ICVD. The criteria presented below have been carefully considered to account for broad applicability to the international community of pediatricians, otolaryngologists, neurologists, neurosurgeons, neuro-otologists physiotherapists, neurophysiologists, and audiologists who may be seeing patients with these syndromes.
van de Berg R., Widdershoven J., Bisdorff A., Evers S., Wiener-Vacher S., Cushing S.L., Mack K.J., Kim J.S., Jahn K., Strupp M, & Lempert T. (2021). Vestibular migraine and recurrent vertigo of childhood: Diagnostic criteria consensus document of the Classification Committee of Vestibular Disorders of the Bárány Society and the International Headache Society. Journal of Vestibular Research, 31(1), 1-9.
Publication 2020
Audiologist Committee Members Diagnosis Headache Migraine Disorders Neurologists Neurosurgeon Otolaryngologist Otologists Patients Pediatricians Physical Therapist Syndrome Vertigo Vestibular Diseases Vestibular Labyrinth

Most recents protocols related to «Vertigo»

1
Lingering COVID-19 Symptoms Prevalence
Residual symptoms were defined as any COVID-19-related symptoms that lasted at least 4 weeks after symptom onset (Centers for Disease Control and Prevention, 2021b). Residual symptoms included respiratory problems (e.g., dyspnea, chest discomfort, cough, and fatigue), CNS symptoms (e.g., loss or reduction of smell/taste, mental fog, dizziness, and vertigo), and musculoskeletal complaints. In the analytic sample, N = 306 (31.1%) participants reported at least one residual COVID-19 symptom. A binary analytic variable was created to compare participants with and without at least one residual symptoms.
Waszczuk M.A., Morozova O., Lhuillier E., Docherty A.R., Shabalin A.A., Yang X., Carr M.A., Clouston S.A., Kotov R, & Luft B.J. (2023). Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders. PLOS ONE, 18(3), e0282271.
Publication 2023
Chest Cough COVID 19 Dyspnea Fatigue Mental Fatigue Respiratory Rate Sense of Smell Taste Vertigo
2
Dizziness Evaluation in Suspected Stroke
We performed a cross-sectional analysis based on adult patient visits to one of three EDs in a healthcare system between 1/1/2014-12/31/2017. The first ED is a comprehensive stroke center, the second is a primary stroke center, the last is a smaller community ED. Adult (age ≥18 years) patient encounters with a chief complaint of dizziness who received CTA head and neck imaging were included for the analysis. Adult “stroke code” encounters during the same time period, with NIHSS ≤ 7 and a positive review of systems for dizziness were also obtained for a sensitivity analysis in patients presenting within the treatment window with high suspicion of stroke. An NIHSS cut off 7 was chosen based on prior literature showing that patients with NIHSS > 7 have greater risk of LVO, independent of presenting with dizziness [6 (link), 14 (link)]. Additional details of patient eligibility for CTA imaging are provided in Item 1 in S1 File.
The study was approved by the Yale University IRB with consent waived. The decision rule was developed with reference to the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) guidelines [15 (link)].
Tu L.H., Malhotra A., Venkatesh A.K., Taylor R.A., Sheth K.N., Yaesoubi R., Forman H.P., Sureshanand S, & Navaratnam D. (2023). Clinical criteria to exclude acute vascular pathology on CT angiogram in patients with dizziness. PLOS ONE, 18(3), e0280752.
Publication 2023
Adult Cerebrovascular Accident Diagnosis Eligibility Determination Head Hypersensitivity Neck Patients Prognosis
3
Sensitivity Analysis of Stroke Decision Rule
The decision rule was applied to the temporally separated testing cohort, with performance compared to the NIHSS. A sensitivity analysis for hyperacute presentations was also performed, by applying the rule to “stroke code” presentations with dizziness (within the review of systems) and a NIHSS ≤ 7.
Tu L.H., Malhotra A., Venkatesh A.K., Taylor R.A., Sheth K.N., Yaesoubi R., Forman H.P., Sureshanand S, & Navaratnam D. (2023). Clinical criteria to exclude acute vascular pathology on CT angiogram in patients with dizziness. PLOS ONE, 18(3), e0280752.
Publication 2023
Cerebrovascular Accident Hypersensitivity
4
Vestibular Disorder Diagnosis Criteria
According to the time characteristics of vestibular symptoms onset, patients can be classified into acute, episodic, or chronic vestibular syndrome (AVS, EVS, or CVS) (21 (link)). All diagnoses were made by the senior authors (ZXW and XY) according to widely accepted diagnostic criteria for each vestibular disorder or the international classification of vestibular disorders (ICVD) criteria when available (22 (link)–26 (link)). The published diagnostic criteria consensus includes acute unilateral vestibulopathy (AUVP)/VN (26 (link)), persistent postural-perceptual dizziness (PPPD) (23 (link)), VM (25 (link)), VM of childhood (24 (link)), and MD (22 (link)). Besides, probably labyrinthine infarction was diagnosed in older patients with sudden onset of unilateral deafness and vertigo, especially when there is a history of stroke or known vascular risk factors (27 (link)). Benign recurrent vertigo (BRV) was diagnosed when patients showed spontaneous rotational vertigo or instability; symptoms that were not triggered by changes in position, lasting longer than 1 min; normal audiogram or symmetric hearing loss; no cochlear symptoms (tinnitus or stuffiness) during the attack phase; no migraine or migraine aura in the acute phase (26 (link), 28 (link)). Isolated acute unilateral utricular vestibulopathy was diagnosed in patients with acute onset of postural imbalance, which can be diagnosed by ocular VEMP (26 (link)).
Ling X., Wu Y.X., Feng Y.F., Zhao T.T., Zhao G.P., Kim J.S., Yang X, & Wang Z.X. (2023). Spontaneous nystagmus with an upbeat component: Central or peripheral vestibular disorders?. Frontiers in Neurology, 14, 1106084.
Publication 2023
Benign Paroxysmal Positional Vertigo Blood Vessel Cerebrovascular Accident Cochlea Deafness, Sudden Eye Hearing Impairment Hearing Tests Infarction Labyrinth Migraine Disorders Migraine with Aura Patients Syndrome Tinnitus Vertigo Vestibular Diseases Vestibular Labyrinth
5
Evaluation of Semicircular Nystagmus
The medical records of 43 patients with SN with an upbeat component were reviewed, including disease course, onset form, duration, frequency of attacks, precipitating/relieving factors, symptoms, signs, history, eye movement examination, caloric test, video head impulse test (vHIT, Interacoustics, Middelfart, Denmark), vestibular-evoked myogenic potentials (VEMPs), head magnetic resonance imaging (MRI), three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging (3D-FLAIR MRI) and serum immunology test results and diagnosis. 2D-VOG (Interacoustics, Middelfart, Denmark) was performed for the detection of SN, gaze-evoked nystagmus, saccades, smooth pursuit, optokinetic, head-shaking nystagmus, and positional test. All patients underwent VOG examination during the acute phase or attack phase. The VOG examination was performed on the day of the visit for patients with acute attacks if they could cooperate with the examination. For patients with severe dizziness/vertigo that cannot cooperate with the examination, a VOG test should be performed within seven days of the latest attack.
All experiments followed the tenets of the Declaration of Helsinki and were approved by the Institutional Review Board of Aerospace Center Hospital.
Ling X., Wu Y.X., Feng Y.F., Zhao T.T., Zhao G.P., Kim J.S., Yang X, & Wang Z.X. (2023). Spontaneous nystagmus with an upbeat component: Central or peripheral vestibular disorders?. Frontiers in Neurology, 14, 1106084.
Publication 2023
Caloric Tests Diagnosis Disease Progression Ethics Committees, Research Eye Movements Head Head Impulse Test Immunologic Tests Inversion, Chromosome Nuclear Magnetic Resonance Pathologic Nystagmus Patients Pursuit, Smooth Serum Tin Vertigo Vestibular Evoked Myogenic Potentials

Top products related to «Vertigo»

1
Sas 9 by SAS Institute
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
2
Sas version 9 by SAS Institute
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
3
Spss version 24 by IBM
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, China, Spain, Ireland
SPSS version 24 is a statistical software package developed by IBM. It provides a comprehensive set of tools for data analysis, including techniques for descriptive statistics, regression analysis, and predictive modeling. The software is designed to help users interpret data, identify trends, and make informed decisions based on statistical insights.
4
Spss ver 21 by IBM
Sourced in United States
SPSS ver. 21.0 is a statistical software package developed by IBM. It is designed to facilitate data analysis, data management, and data visualization. The software provides a range of analytical tools and techniques to help users interpret and understand their data.
5
Sas statistical software by SAS Institute
Sourced in United States, Austria, Japan, Cameroon
SAS statistical software is a comprehensive data analysis and visualization tool. It provides a wide range of statistical procedures and analytical capabilities for managing, analyzing, and presenting data. The software is designed to handle large and complex datasets, allowing users to perform advanced statistical modeling, regression analysis, and data mining tasks. The core function of the SAS statistical software is to enable users to extract insights and make data-driven decisions.
6
Nucleus 5 by Cochlear
Sourced in Australia
The Nucleus 5 is a state-of-the-art cochlear implant system designed for individuals with severe-to-profound sensorineural hearing loss. It features a compact, lightweight external sound processor that delivers high-quality audio signals to the internal implant, enabling improved hearing and speech recognition.
7
Spss statistic by IBM
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, Italy, Poland, India, Canada, Switzerland, Spain, China, Sweden, Brazil, Australia, Hong Kong
SPSS Statistics is a software package used for interactive or batched statistical analysis. It provides data access and management, analytical reporting, graphics, and modeling capabilities.
8
Spss software version 22 by IBM
Sourced in United States, Japan, Belgium, United Kingdom, Germany
SPSS software version 22.0 is a comprehensive statistical analysis tool designed to handle a wide range of data types and perform advanced analytical tasks. The software provides a user-friendly interface and a robust set of statistical procedures, enabling researchers, analysts, and professionals to effectively analyze and interpret data.
9
Spss 22.0 software for windows by IBM
Sourced in United States
SPSS 22.0 is a statistical software package for Windows designed to analyze and manage data. It provides a wide range of statistical and analytical tools to help users process, visualize, and interpret data. The software is widely used in academic, research, and business settings.

More about "Vertigo"

Vertigo, a common condition characterized by a sensation of dizziness or spinning, can significantly impact an individual's quality of life, making it challenging to perform everyday tasks.
This phenomenon, often accompanied by a loss of balance or disorientation, can be caused by a variety of underlying factors, including inner ear disorders, neurological problems, or medication side effects.
Researchers studying vertigo may find PubCompare.ai to be a valuable tool in optimizing their research efforts.
This AI-driven platform allows researchers to locate protocols from literature, preprints, and patents, facilitating the identification of the most effective protocols and products.
By utilizing PubCompare.ai, researchers can enhance the reproducibility and accuracy of their vertigo-related studies, ultimately leading to improved patient outcomes.
In addition to PubCompare.ai, researchers may also benefit from utilizing statistical software such as SAS version 9.4, SPSS version 24, and SPSS version 21.0.
These tools can provide valuable insights and support in analyzing data related to vertigo research.
Furthermore, the Nucleus 5 software and SPSS Statistics version 22.0 can also be leveraged to enhance the rigor and precision of vertigo-related studies.
By incorporating these resources and strategies, researchers can optimize their vertigo research, improve the quality of their findings, and contribute to the advancement of our understanding and treatment of this debilitating condition.
Remember, a single typo can add a natural feel to the content, so don't be afraid to include one in your writing.